Zogenix Inc ZGNX

NAS: ZGNX | ISIN: US98978L2043 4/03/2022

26,68 USD (+1,60%)

(+1,60%) 4/03/2022

Toon enkel gratis nieuws

7 maart 2022 · UCB Completes Acquisition of Zogenix, Inc. · Persbericht

26 januari 2022 · BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zogenix, Inc. (Nasdaq - ZGNX), Social Capital Suvretta Holdings Corp. III (Nasdaq - DNAC), Viveon Health Acquisition Corp. (NYSE American - VHAQ) · Persbericht

19 januari 2022 · UCB to acquire Zogenix · Persbericht

11 februari 2021 · Zogenix to Release Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25 · Persbericht

1 februari 2021 · Zogenix’s FINTEPLA® (Fenfluramine) Oral Solution Now Available in Germany for the Treatment of Seizures in Dravet Syndrome · Persbericht

11 januari 2021 · Zogenix Announces Preliminary, Unaudited Fourth Quarter 2020 Net Product Sales · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe